Related Experiment Videos
Finasteride-induced myalgia and HyperCKemia
Talal M Al-Harbi1, Jennifer Kagan, Mark A Tarnopolsky
1Neurology Division, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Background:
Finasteride is an antiandrogen, inhibits type II 5-alpha reductase (enzyme that converts testosterone to more potent form dihydrotestosterone), and is commonly used in the treatment of benign prostatic hyperplasia and male frontal baldness; however, it is not free from side effects, which include sexual dysfunction and, rarely, myopathy. We report a case of finasteride-associated myalgia and hyperCKemia and review similar cases reported in the literature.
Case Report:
A 30-year-old man who had been taking finasteride 5 mg/d for 10 years to treat frontal baldness developed diffuse muscle aches associated with elevated creatine kinase level to 10,117 IU/L with neither weakness nor pigmenturia. His symptoms resolved and his creatine kinase level dropped down to 256 IU/L 3 weeks after finasteride discontinuation.
Conclusion:
Reversible myalgia associated with significant hyperCKemia is a possible adverse reaction of finasteride therapy.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Hyperglycemia
Hyperthyroidism II: Pathophysiology
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...